Hans Olav Melberg
Research director
Contact
Mob: +47 936 58 818
Department
Responsibilities
Organization of health care systems, incentives, payment systems, analysis of register data (python, R), cost-benefit evaluations, causal inference
Projects and publications
- Karoline Anisdahl, Sandre Svatun Lirhus, Asle Wilhelm Medhus, Bjørn Allan Moum, Hans Olav Melberg, Marte Lie Høivik, (2024). Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study. Digestive and Liver Disease doi: 10.1016/j.dld.2024.02.002
- Hans Olav Melberg, (2023). Nyttig perspektiv på overvektig populasjon. Tidsskrift for Den norske legeforening (Tidsskriftet) doi: 10.4045/tidsskr.23.0593
- Johan Burisch, Mirabella Zhao, Selwyn Odes, Peter De Cruz, Severine Vermeire, Charles N Bernstein, Gilaad G Kaplan, Dana Duricova, Dan Greenberg, Hans Olav Melberg, Mamoru Watanabe, Hyeong Sik Ahn, Laura Targownik, Valérie E H Pittet, Vito Annese, K.T. Park, Konstantinos H Katsanos, Marte Lie Høivik, Zeljko Krznaric, María Chaparro, Edward V Loftus, Peter L Lakatos, Javier P Gisbert, Willem Bemelman, Bjørn Allan Moum, Richard B Gearry, Michael D Kappelman, Ailsa Hart, Marieke J Pierik, Jane M Andrews, Siew C Ng, Renata D'Inca, Pia Munkholm, (2023). The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission. The Lancet Gastroenterology and Hepatology s. 458-492. doi: 10.1016/S2468-1253(23)00003-1
- Kristina Malene Ødegaard, Sandre Svatun Lirhus, Hans Olav Melberg, Jonas Hallen, Sigrun Halvorsen, (2022). Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014–2020. ESC Heart Failure doi: 10.1002/ehf2.14206
- Mirabella Zhao, Sandre Svatun Lirhus, Mikael Lördal, Ebbe Langholz, Torben Knudsen, Markku Voutilainen, Marte Lie Høivik, Bjørn Allan Moum, Karoline Anisdahl, Borghild Sæbø, Paula Haiko, Carolina Malmgren, Mehmet Coskun, Hans Olav Melberg, Johan Burisch, (2022). Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway. Alimentary Pharmacology and Therapeutics s. 989-1006. doi: 10.1111/apt.17145
- Kristina Malene Ødegaard, Sandre Svatun Lirhus, Hans Olav Melberg, Jonas Hallen, Sigrun Halvorsen, (2022). A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates. BMC Cardiovascular Disorders doi: 10.1186/s12872-022-02522-y
- Christoffer Bugge, Stein Kaasa, Erik Magnus Sæther, Hans Olav Melberg, Ivar Sønbø Kristiansen, (2021). What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study. BMJ Open s. 1-7. doi: 10.1136/bmjopen-2021-050564
- Karoline Anisdahl, Sandre Svatun Lirhus, Asle Wilhelm Medhus, Bjørn Moum, Hans Olav Melberg, Marte Lie Høivik, (2021). First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study. Scandinavian Journal of Gastroenterology s. 1-7. doi: 10.1080/00365521.2021.1955147
- Reidar Fossmark, Maya Olaisen, Tom Christian Martinsen, Hans Olav Melberg, (2021). Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study. Therapeutic Advances in Gastroenterology s. 1-10. doi: 10.1177/17562848211021760
- Snorre Kverndokk, Hans Olav Melberg, (2021). Using fees to reduce bed-blocking: a game between hospitals and long-term care providers. European Journal of Health Economics s. 931-949. doi: 10.1007/s10198-021-01299-9
- Sandre Svatun Lirhus, Marte Lie Høivik, Bjørn Moum, Karoline Anisdahl, Hans Olav Melberg, (2021). Incidence and prevalence of inflammatory bowel disease in norway and the impact of different case definitions: A nationwide registry study. Clinical Epidemiology s. 287-294. doi: 10.2147/CLEP.S303797
- Kristina Malene Ødegaard, Jonas Hallen, Sandre Svatun Lirhus, Hans Olav Melberg, Sigrun Halvorsen, (2020). Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013-2016 . ESC Heart Failure doi: 10.1002/ehf2.12773
- Hans Olav Melberg, Lars Asphaug, (2019). Health Economics and Fatty Liver Disease. s. 81-86. doi: 10.1007/978-3-319-98890-0_5
- Lars Asphaug, Maja Thiele, Aleksander Krag, Hans Olav Melberg, (2019). Cost‐Effectiveness of Noninvasive Screening for Alcohol‐Related Liver Fibrosis. Hepatology doi: 10.1002/hep.30979
- Lars Asphaug, Hans Olav Melberg, (2019). The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway. Medical Decision Making Policy & Practice s. 1-19. doi: 10.1177/2381468318821103
- Elin Kjelle, Linn Kleven, Hilde M Olerud, Hans Olav Melberg, (2018). Cost analysis of mobile radiography services for nursing home residents in Southeast Norway. Journal of Evaluation In Clinical Practice doi: 10.1111/jep.13058
- Sandre Svatun Lirhus, Marte Lie Høivik, Bjørn Moum, Hans Olav Melberg, (2018). Regional differences in anti-TNF-a therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study. Scandinavian Journal of Gastroenterology s. 952-957. doi: 10.1080/00365521.2018.1495258
- Camilla Beck Olsen, Hans Olav Melberg, (2018). Did adolescents in Norway respond to the elimination of copayments for general practitioner services?. Health Economics s. 1120-1130. doi: 10.1002/hec.3660
- Hans Olav Melberg, (2017). Samhandlingsreformen og kausal inferens . Michael quarterly. Supplement s. 119-126.
- Jan Blomqvist, Raitasalo Kirsimarja, Hans Olav Melberg, Dirk Schreckenberg, Christine Peschel, Justyna klingemann, anja Koski-Jännes, (2016). Popular images of addiction in five European countries. doi: 10.1093/acprof:oso/9780198737797.003.0010
- Terje P. Hagen, Hans Olav Melberg, (2016). Liggetider og reinnleggelser før og etter Samhandlingsreformen.. Tidsskrift for omsorgsforskning s. 143-158. doi: 10.18261/issn.2387-5984-2016-02-09
- Hans Olav Melberg, Camilla Beck Olsen, Kine Pedersen, (2016). Did hospitals respond to changes in weights of Diagnosis Related Groups in Norway between 2006 and 2013?. Health Policy s. 992-1000. doi: 10.1016/j.healthpol.2016.07.013
- Camilla Beck Olsen, Hans Olav Melberg, (2016). Påvirker egenandeler ungdoms legebesøk?. Tidsskrift for velferdsforskning s. 62-75. doi: 10.18261/issn.2464-3076-2016-01-04
- Justin E. Bekelman, Scott D. Halpern, Carl Rudolf Blankart, Julie P. Bynum, Joachim Cohen, Robert Fowler, Stein Kaasa, Lukas Kwietniewski, Hans Olav Melberg, Bregje D. Onwuteaka-Philipsen, Mariska Oosterveld-Vlug, Andrew Pring, Jonas Schreyögg, Connie M. Ulrich, Julia Verne, Hannah Wunsch, Ezekiel J. Emanuel, (2016). Comparison of site of death, health care utilization, and hospital expenditures for patients dying With cancer in 7 developed countries. Journal of the American Medical Association (JAMA) s. 272-283. doi: 10.1001/jama.2015.18603
- Trygve Ottersen, Reidun Førde, Meetali Kakad, Alice Kjellevold, Hans Olav Melberg, Atle Moen, Ånen Ringard, Ole Frithjof Norheim, (2016). A new proposal for priority setting in Norway: Open and fair. Health Policy s. 246-251. doi: 10.1016/j.healthpol.2016.01.012
- Hans Olav Melberg, Ida Eriksen, (2015). The effects of introducing an electronic prescription system with no copayments. Health Economics Review s. 2-21. doi: 10.1186/s13561-015-0056-4
- Emma Medin, Fanny Goude, Hans Olav Melberg, Fabrizio Tediosi, Eva Belicza, Mikko Peltola, (2015). European regional differences in all-cause mortality and length of stay for patients with hip fracture. Health Economics s. 53-64. doi: 10.1002/hec.3278
- Ida Eriksen, Hans Olav Melberg, (2014). Endringer over tid i legers holdninger til kostnader. s. 159-172.
- Fredrik Alexander Gregersen, Hans Olav Melberg, (2014). I hvor stor grad vil eldrebølgen bidra til økte helsekostnader? -En studie av ulike framskrivningsmetoder for helsekostnader. Samfunnsøkonomen s. 32-37.
- Ida Eriksen, Hans Olav Melberg, Berit Bringedal, (2013). Norwegian Physicians' Knowledge of the Prices of Pharmaceuticals: A Survey. PLOS ONE doi: 10.1371/journal.pone.0075218
- Hans Olav Melberg, Edmund Henden, Olav Gjelsvik, (2013). Addiction and Responsibility: A Survey of Opinions. Inquiry (Oslo) s. 558-570. doi: 10.1080/0020174X.2013.806143
- Edmund Henden, Hans Olav Melberg, Ole Røgeberg, (2013). Addiction: choice or compulsion?. Frontiers in Psychiatry s. 1-11. doi: 10.3389/fpsyt.2013.00077
- Hans Olav Melberg, Geir Godager, Fredrik Gregersen, (2013). Sykehusutgifter mot livets slutt. Tidsskrift for Den norske legeforening (Tidsskriftet) s. 841-844. doi: 10.4045/tidsskr.12.0802
- Peter C. Rockers, Andrea B. Feigl, John-Arne Røttingen, Atle Fretheim, David de Ferranti, John N Lavis, Hans Olav Melberg, Till Bärnighausen, (2012). Study-design selection criteria in systematic reviews of effectiveness of health systems interventions and reforms: A meta-review. Health Policy s. 206-214. doi: 10.1016/j.healthpol.2011.12.007
- Hans Olav Melberg, Lars Erik Kjekshus, (2012). Innledning. s. 7-12.
- Hans Olav Melberg, Lars Erik Kjekshus, (2012). Mot en begrenset rasjonell helsepolitikk?. s. 283-288.
- Hans Olav Melberg, Karl Erik Lund, (2012). Do smoke-free laws affect revenues in pubs and restaurants?. European Journal of Health Economics s. 93-99. doi: 10.1007/s10198-010-0287-6
- Hans Olav Melberg, (2012). Eldrebølgen: bedre enn sitt rykte. s. 57-66.
- Hans Olav Melberg, Pekka Hakkarainen, Esben Houborg, Marke Jääskeläinen, Astrid Skretting, Mats Ramstedt, Pia Rosenqvist, (2011). Measuring the harm of illicit drug use on friends and family. Nordic Studies on Alcohol and Drugs (NAD) s. 105-121. doi: 10.2478/v10199-011-0012-5
- Ole Jørgen Røgeberg, Hans Olav Melberg, (2011). Acceptance of unsupported claims about reality - A blind spot in economics. Journal of Economic Methodology s. 29-52. doi: 10.1080/1350178X.2011.556817
- Hans Olav Melberg, (2011). Measuring the human costs of drug use for friends and family of drug users. The results from a survey in four Nordic capitals. Nordic Studies on Alcohol and Drugs (NAD) s. 105-121.
- Hans Olav Melberg, Keith Humpreys, (2010). Ineligibility and refusal to participate in randomised trials of treatments for drug dependence. Drug and Alcohol Review s. 193-201.
- Hans Olav Melberg, (2010). Hva tror legene en MR-undersøkelse koster?. Tidsskrift for Den norske legeforening (Tidsskriftet) s. 598-600.
- Hans Olav Melberg, (2010). Conceptual problems with studies of the social cost of alcohol. Nordic Studies on Alcohol and Drugs (NAD) s. 287-303.
- Hans Olav Melberg, Ole Jørgen Røgeberg, (2010). Rational addiction theory – A survey of opinions. Journal of Drug Policy Analysis doi: 10.2202/1941-2851.1019
- Hans Olav Melberg, Andrew Michael Jones, Anne Line Bretteville-Jensen, (2010). Is cannabis a gateway to hard drugs?. Empirical Economics s. 583-603. doi: 10.1007/s00181-009-0280-z
- Hans Olav Melberg, (2010). Animal spirits: Fargerik tomhet?. Samfunnsøkonomen s. 4-10.
- Hans Olav Melberg, Eline Aas, Ingrid Hjort, lars Vorland, Mathias Barra, Hallstein Husbyn, Maren Kristine Raknes Sogstad, Åsmund Flobak, Gudrun Maria Waaler Bjørnelv, Gunn Oddlaug Strand Hutchinson, (2024). Perspektiv og prioriteringer: Rapport fra ekspertgruppen perspektiv i prioritering nedsatt av Helse- og omsorgdepartementet.
- Steinar Holden, Oona Borghild Dunlop, Styrk Fjærtoft Vik, Ingrid Hjort, Simen Markussen, Hans Olav Melberg, Anne Spurkland, Thomas Rolf Lydersen Lystad von Brasch, Karen Walseth Hara, Katrine Vellesen Løken, Håvard Hungnes, Gunnar Øyvind Isaksson Rø, Kjartan Sælensminde, Vera Haugen Kvisgaard, Karine Nordstrand, (2022). Holden-IV (covid-19) Hovedrapport: Samfunnsøkonomiske vurderinger av smitteverntiltak.
- Tore Tennøe, Hilde Lovett, Erik Fosse, Siri B Hatlen, Steinar Madsen, Damoun Nassehi, Hans Olav Melberg, Michael Riegler, (2019). Kunstig Intelligens og Norske Helsedata.
- Hilde Lovett, Damoun Nassehi, Erik Fosse, Siri B Hatlen, Steinar Madsen, Hans Olav Melberg, Michael Riegler, (2018). Kunstig Intelligens - Muligheter, Utfordringer og en Plan for Norge.
- Hilde Lovett, Tore Tennøe, Ola Dale, Nils Jørgen Langtvedt, Hans Olav Melberg, Steinar Madsen, Damoun Nassehi, Marie Nora Roald, (2016). Mobile Selvtester.
- Hans Olav Melberg, Lars Erik Kjekshus, (2012). Fremtidens Helse-Norge.
- Hans Olav Melberg, Øivind Schøyen, (2012). Hvordan påvirker redusert skjenketid omsetningen i utelivsbransjen? Nettrapport.
- Karl Erik Lund, Elisabeth Kvaavik, Hans Olav Melberg, Jostein Rise, (2010). Oppdatering av kunnskapsgrunnlaget om forbud mot synlig oppstilling av tobakksvarer. Notat fra Statens institutt for rusmiddelforskning (SIRUS) 20. desember 2010.
- Gudrun Maria Waaler Bjørnelv, Hans Olav Melberg, (2023). Penger, prinsipper og prioritering. Tidsskrift for Den norske legeforening (Tidsskriftet) doi: 10.4045/tidsskr.23.0210
- Reidar Fossmark, Maya Olaisen, Tom Christian Martinsen, Hans Olav Melberg, (2020). P760 Differences in persistence of oral mesalazine preparations as monotherapy in patients with ulcerative colitis . Journal of Crohn's and Colitis s. S605-S606. doi: 10.1093/ecco-jcc/jjz203.888
- Reidar Fossmark, Maya Olaisen, Tom Christian Martinsen, Hans Olav Melberg, (2020). Forskjeller i medikamentoverlevelse mellom perorale mesalazin-preparater som monoterapi ved ulcerøs colitt.
- Hans Olav Melberg, (2019). Value in health: How it is defined and used in priority setting and pricing in Norway. HealthcarePapers s. 22-28. doi: 10.12927/hcpap.2019.25929
- Hans Olav Melberg, (2018). Registertilgang i molboland?. Dagens medisin
- Hans Olav Melberg, (2018). Obama-reformen – og norsk helsepolitikk. Dagens medisin
- Hans Olav Melberg, (2018). Helse-Norge trenger tvil – ikke bare heiarop. Dagens medisin
- Hans Olav Melberg, (2018). Hvorfor koster diamanter mer enn vann?. Dagens medisin
- Phoi Phoi Diep, Hans Olav Melberg, Lorentz Brinch, Jochen Buechner, Yngvar Fløisand, Thobias Gedde-Dahl, Jon Håvard Loge, Geir Erland Tjønnfjord, Ellen Ruud, (2018). Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway. Bone Marrow Transplantation s. 657-660. doi: 10.1038/s41409-018-0091-y
- Elin Kjelle, Linn Kleven, Hilde M Olerud, Hans Olav Melberg, (2018). Radiography on wheels for nursing home residents may reduce healthcare costs.
- Phoi Phoi Diep, Hans Olav Melberg, Lorentz Brinch, Jochen Buechner, Yngvar Fløisand, Thobias Gedde-Dahl, Geir Erland Tjønnfjord, Ellen Ruud, (2017). Allogeneic hematopoietic stem cell transplantation in Norway 1974-2009: Cost-utility and survival in children and young adults .
- Hans Olav Melberg, (2016). Skal det være en app –eller to?. Dagens medisin
- Hans Olav Melberg, (2016). Medisiner i ingenmannsland – mens tiden går…. Dagens medisin
- Hans Olav Melberg, (2015). Helse og finansiering i Norge.
- Hans Olav Melberg, (2015). Effekter av politiske reformer: Hvorfor går det ofte galt?.
- Hans Olav Melberg, (2015). Bruker vi de store pengene på de største problemene?.
- Hans Olav Melberg, (2014). Nye regler for prioritering.
- Hans Olav Melberg, (2014). Statsbudsjettet: Raskere og mer private symfonier. Dagens medisin
- Hans Olav Melberg, (2014). Jordbær, finansiering - og informasjon i norsk helsevesen. Dagens medisin
- Hans Olav Melberg, (2014). Hellig helse - og prislapp på slutten av livet?. Dagens medisin
- Hans Olav Melberg, (2014). Struts, sykehjem og søppel?. Dagens medisin
- Hans Olav Melberg, (2014). Intervju om organisering av eldreomsorg i Dagsnytt 18.
- Hans Olav Melberg, (2014). Are healthcare expenditures increasing faster for the elderly than the rest of the population?. Expert review of pharmacoeconomics & outcomes research s. 581-583. doi: 10.1586/14737167.2014.919857
- Hans Olav Melberg, (2014). Prislapp på et liv?.
- Hans Olav Melberg, (2014). Effekten av kommunal mediskrivning for utskrivningsklare pasienter.
- Hans Olav Melberg, (2014). Hva driver helsekostnadene?.
- Hans Olav Melberg, (2013). Hector Estrup, Jesper Jespersen og Peter Nielsen: Den økonomiske teoriens historie: En introduksjon. Tidsskrift for samfunnsforskning (TfS) s. 396-399.
- Hans Olav Melberg, (2013). Er legemiddelindustrien pill råtten?. Dagens medisin
- Hans Olav Melberg, (2013). Projecting future health spending and demography.
- Hans Olav Melberg, (2013). The Harkness Experience.
- Hans Olav Melberg, (2013). Vi må eksperimentere mer!. Dagens medisin
- Hans Olav Melberg, (2013). Unødvendig forvirring om helseutgifter. Tidsskrift for Den norske legeforening (Tidsskriftet) s. 935-935. doi: 10.4045/tidsskr.13.0506
- Hans Olav Melberg, (2013). Den økonomiske teoriens historie: En introduksjon. Tidsskrift for samfunnsforskning (TfS) s. 396-399.
- Hans Olav Melberg, (2013). How does end of life costs and increases in life expectancy affect projections of future health cost?.
- Hans Olav Melberg, Geir Godager, Fredrik Gregersen, (2013). Sykehusutgifter mot slutten av livet. Dagens medisin
- Lars Erik Kjekshus, Hans Olav Melberg, (2012). Ti myter om fremtidens helsevesen. Aftenposten (morgenutg. : trykt utg.)
- Geir Godager, Fredrik Gregersen, Hans Olav Melberg, (2012). Helseutgifter mot slutten av livet: Hvor viktige er dødsfallsrelaterte utgifter ved beregningen av framtidens helseutgifter?.
- Hans Olav Melberg, (2012). Nyttige tilbakemeldinger og provoserende refleksjoner. Tidsskrift for Den norske legeforening (Tidsskriftet) s. 1641-1641. doi: 10.4045/tidsskr.12.0541
- Hans Olav Melberg, (2012). End of life costs in Norway and the US.
- Hans Olav Melberg, (2012). Social cost of alcohol: Not always useless even if subjective?. Nordic Studies on Alcohol and Drugs (NAD) s. 35-359. doi: 10.2478/v10199-012-0030-y
- Hans Olav Melberg, (2012). Bruker Norge mye eller lite til helseformål sammenlignet med andre land?. Perspektiv s. 1-20.
- Hans Olav Melberg, (2012). Svindel i amerikansk helsevesen. Anmeldelse av Terry L. Leap “Phantom Billing, Fake Prescriptions, and the High Cost of Medicine: Health Care Fraud and What to Do about It”. Tidsskrift for Den norske legeforening (Tidsskriftet) doi: 10.4045/tidsskr.11.1248
- Hans Olav Melberg, Terje P. Hagen, (2010). Bruker Norge mye eller lite penger på helse?. Overlegen s. 8-9.
- Hans Olav Melberg, (2010). Høye kostnader ved hasjforbud.Kronikk. Dagbladet